Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Says Review Confirms That Genomics Unit Is Weak, Drug Repositioning Has Legs

NEW YORK (GenomeWeb News) – Gene Logic today said that an internal business review confirmed that the firm's genomics business is weak and that the drug-repositioning business is poised to grow.
 
After reporting a 44-percent decline in revenues for the second quarter, Gene Logic restructured the unit in August to reduce expenses and spending. The restructuring included layoffs and the closing of an office.
 
The company retained “core competencies” for its current products and services and will continue to support existing customers, Gene Logic said.
 
While Gene Logic will try to sign new customers, the company will also make the assets from the genomics business available to other areas, such as drug repositioning, clinical biomarker development, and molecular diagnostics.
 
Gene Logic also said the review “confirmed” the potential of its drug-repositioning business. Recent agreements with Pfizer, Organon, and Roche confirm the industry’s acceptance of the business, the company said.
 
The company expects the preclinical services business to continue improving its operating margins and to narrow losses. The business has sufficient capacity as a result of facility expansions, the review found.
 
The company said in June it would conduct the review after withdrawing its financial guidelines for the second quarter and full year 2006 and 2007.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.